These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Effect of almitrine bismesylate on pulmonary vasoreactivity to hypoxia in chronic obstructive pulmonary disease. Saadjian AY; Philip-Jöel FF; Barret A; Levy S; Arnaud AG Eur Respir J; 1994 May; 7(5):862-8. PubMed ID: 8050541 [TBL] [Abstract][Full Text] [Related]
10. Gas exchange during weaning in patients with chronic obstructive pulmonary disease. Rodriguez-Roisin R Schweiz Med Wochenschr; 1994 Feb; 124(6):221-6. PubMed ID: 8128203 [TBL] [Abstract][Full Text] [Related]
11. [Effect of supplemental oxygen on exercise performance in patients with chronic obstructive pulmonary disease and an arterial oxygen tension over 60 Torr]. Ishimine A; Saito H; Nishimura M; Nakano T; Miyamoto K; Kawakami Y Nihon Kyobu Shikkan Gakkai Zasshi; 1995 May; 33(5):510-9. PubMed ID: 7609336 [TBL] [Abstract][Full Text] [Related]
12. [The effect of inhaled salbutamol on pulmonary gas exchange in patients with chronic obstructive bronchopneumopathy]. Clerbaux T; Henry P; Veriter C; Nullens W; Detry B; Cao ML; Raphael D; Frans A Rev Mal Respir; 1992; 9(2):171-7. PubMed ID: 1565829 [TBL] [Abstract][Full Text] [Related]
13. Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. Goldstein RS; Ramcharan V; Bowes G; McNicholas WT; Bradley D; Phillipson EA N Engl J Med; 1984 Feb; 310(7):425-9. PubMed ID: 6420700 [TBL] [Abstract][Full Text] [Related]
14. Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxemic patients with chronic obstructive pulmonary disease. Comparison with a beta-adrenergic agent. Gross NJ; Bankwala Z Am Rev Respir Dis; 1987 Nov; 136(5):1091-4. PubMed ID: 3118746 [TBL] [Abstract][Full Text] [Related]
15. Effects of chlormadinone acetate, acetazolamide and oxygen on awake and asleep gas exchange in patients with chronic obstructive pulmonary disease (COPD). Vos PJ; Folgering HT; de Boo TM; Lemmens WJ; van Herwaarden CL Eur Respir J; 1994 May; 7(5):850-5. PubMed ID: 7519567 [TBL] [Abstract][Full Text] [Related]
16. The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease. Liss HP; Grant BJ Am Rev Respir Dis; 1988 Jun; 137(6):1285-8. PubMed ID: 3144198 [TBL] [Abstract][Full Text] [Related]
17. Quantitative 15 steps exercise oximetry as a marker of disease severity in patients with chronic obstructive pulmonary disease. Kramer MR; Krivoruk V; Lebzelter J; Liani M; Fink G Isr Med Assoc J; 1999 Nov; 1(3):165-8. PubMed ID: 10731326 [TBL] [Abstract][Full Text] [Related]
18. Effects of buprenorphine on cardiovascular and pulmonary function in clinically normal horses and horses with chronic obstructive pulmonary disease. Szöke MO; Blais D; Cuvelliez SG; Lavoie JP Am J Vet Res; 1998 Oct; 59(10):1287-91. PubMed ID: 9781463 [TBL] [Abstract][Full Text] [Related]
19. [Hypercapnic and hypoxic ventilatory responses in patients with chronic obstructive pulmonary disease]. Suzuki S Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():120-7. PubMed ID: 1306214 [TBL] [Abstract][Full Text] [Related]